Table 3. Allele burden and expression of JAK2 V617F mutation.
Patient (N°) | MNP | JAK2 V617F gAB[%]* | JAK2 V617F cAB [%]* |
1 | PV | 34.8 | 99.9 |
2 | PV | 92.6 | 83.4 |
3 | PV | 53.08 | 57.3 |
4 | PV | 19.3 | 12.8 |
5 | PV | 97.27 | 97.3 |
6 | PV | 80.3 | 78.6 |
7 | ET | 39.5 | 45.7 |
8 | ET | 67.7 | 45.7 |
9 | ET | 45.1 | 53.3 |
10 | ET | 31.5 | 35.02 |
11 | ET | 81.1 | 89.9 |
12 | MF | 86.2 | 99.8 |
13 | MF | 93.05 | 90.1 |
14 | MF | 62.3 | 94.1 |
15 | MF | 60.1 | 99.9 |
16 | MF | 98.6 | 99.8 |
17 | MF | 67.18 | 99.3 |
18† | MF | 0.54 | 5.21E-04 |
19 | MF | 83.4 | 99.9 |
20 | MF | 91.2 | 95.4 |
The propagated error (SD) of the AB from individual values of MT and WT measurements was negligible; therefore, it was not considered (range 6.37×10−8–1.5310−5).
Case N° 18 was negative for the JAK2 V617F mutation.